Pieris Phar­ma­ceu­ti­cals lays off 70% of work­force af­ter As­traZeneca ends asth­ma med­i­cine part­ner­ship

Pieris Phar­ma­ceu­ti­cals is lay­ing off about 70% of its work­force in a “cor­po­rate re­struc­tur­ing” to pre­serve cash a lit­tle less than a month af­ter As­traZeneca …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER